Description: Abingdon Health Plc, a technology-enabled lateral flow diagnostics company, develops, manufactures, and markets medical diagnostics worldwide. The company offers AbC-19 Rapid Test, a COVID-19 neutralizing antibody test; nucleic acid lateral flow immunoassays; and Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum. It also provides lateral flow development, manufacturing, and reader customization services. The company was founded in 2008 and is headquartered in York, the United Kingdom.
Home Page: www.abingdonhealth.com
ABDX Technical Analysis
York Biotech Campus
York,
YO41 1LZ
United Kingdom
Phone:
44 19 0440 6050
Officers
| Name | Title |
|---|---|
| Mr. Chris Henry Francis Yates | CEO & Director |
| Ms. Melanie Ross | CFO, Company Sec. & Director |
| Mr. Mark Jones | Chief Operating Officer |
| Ms. Brenda Hogan | HR Director |
| Mr. Oliver Gardner | Chief Commercial Officer |
| Ms. Nina Garrett | Head of Assay Devel. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8516 |
| Price-to-Sales TTM: | 1.8184 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 71 |